Literature DB >> 23744859

Bleomycin-induced flagellate hyperpigmentation.

Cristina Resende1, Catarina Araújo, Joana Gomes, Celeste Brito.   

Abstract

Bleomycin is a chemotherapeutic agent used in the treatment of different tumours. It has several side effects, including flagellate hyperpigmentation, which is a unique and a well-documented side effect of bleomycin therapy. We report a case of a 23-year-old woman with a personal history of ovarian dysgerminoma, who developed flagellate hyperpigmentation on trunk after bleomycin therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23744859      PMCID: PMC3702889          DOI: 10.1136/bcr-2013-009745

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Bleomycin-induced flagellate pigmentation.

Authors:  M G Nigro; S Hsu
Journal:  Cutis       Date:  2001-10

2.  Images in clinical medicine. Bleomycin-induced flagellate hyperpigmentation.

Authors:  Omar A Ibrahimi; R Rox Anderson
Journal:  N Engl J Med       Date:  2010-12-09       Impact factor: 91.245

3.  Flagellate pigmentation: a unique adverse effect of bleomycin therapy.

Authors:  Sultan Al-Khenaizan; Bassim Al-Berouti
Journal:  Eur J Dermatol       Date:  2011 Jan-Feb       Impact factor: 3.328

Review 4.  Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris.

Authors:  Alexander Abess; Douglas M Keel; Brad S Graham
Journal:  Arch Dermatol       Date:  2003-03

5.  Bleomycin induced flagellate pigmentation.

Authors:  Lalit Kumar Gupta; R K Tanwar; Ashok Kumar Khare; Suresh Kumar Jain
Journal:  Indian J Dermatol Venereol Leprol       Date:  2002 May-Jun       Impact factor: 2.545

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.